Examining unit costs for COVID-19 case management in Kenya
Authors:
Open Access
- 14 April 2021
- journal article
- research article
- Published by BMJ in BMJ Global Health
- Vol. 6 (4) , e004159
Abstract
Introduction We estimated unit costs for COVID-19 case management for patients with asymptomatic, mild-to-moderate, severe and critical COVID-19 disease in Kenya. Methods We estimated per-day unit costs of COVID-19 case management for patients. We used a bottom-up approach to estimate full economic costs and adopted a health system perspective and patient episode of care as our time horizon. We obtained data on inputs and their quantities from data provided by three public COVID-19 treatment hospitals in Kenya and augmented this with guidelines. We obtained input prices from a recent costing survey of 20 hospitals in Kenya and from market prices for Kenya. Results Per-day, per-patient unit costs for asymptomatic patients and patients with mild-to-moderate COVID-19 disease under home-based care are 1993.01 Kenyan shilling (KES) (US$18.89) and 1995.17 KES (US$18.991), respectively. When these patients are managed in an isolation centre or hospital, the same unit costs for asymptomatic patients and patients with mild-to-moderate disease are 6717.74 KES (US$63.68) and 6719.90 KES (US$63.70), respectively. Per-day unit costs for patients with severe COVID-19 disease managed in general hospital wards and those with critical COVID-19 disease admitted in intensive care units are 13 137.07 KES (US$124.53) and 63 243.11 KES (US$599.51). Conclusion COVID-19 case management costs are substantial, ranging between two and four times the average claims value reported by Kenya’s public health insurer. Kenya will need to mobilise substantial resources and explore service delivery adaptations that will reduce unit costs.Keywords
All Related Versions
Funding Information
- Wellcome Trust (092654)
- international Decision Support Initiative (N/A)
This publication has 9 references indexed in Scilit:
- Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donorsScience, 2021
- Epidemiology of COVID‐19: A systematic review and meta‐analysis of clinical characteristics, risk factors, and outcomesJournal of Medical Virology, 2020
- Essential care of critical illness must not be forgotten in the COVID-19 pandemicThe Lancet, 2020
- WHO Declares COVID-19 a Pandemic2020
- Examining purchasing reforms towards universal health coverage by the National Hospital Insurance Fund in KenyaInternational Journal for Equity in Health, 2020
- Measuring progress towards Sustainable Development Goal 3.8 on universal health coverage in KenyaBMJ Global Health, 2018
- Methods for the Economic Evaluation of Health Care Programmes2005
- Programme costs in the economic evaluation of health interventionsCost Effectiveness and Resource Allocation, 2003
- Allowing for differential timing in cost analyses: discounting and annualizationHealth Policy and Planning, 2002